The impact of 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease: a literature review (Q38080478)

28 August 2017

title

The impact of 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease: a literature review (English)

1 reference

pneumococcal conjugate vaccine

28 August 2017

main subject

1 reference

Tin Tin Htar Myint

1

1 reference

28 August 2017

Harish Madhava

2

1 reference

28 August 2017

Paul Balmer

3

1 reference

28 August 2017

Dina Christopoulou

4

1 reference

28 August 2017

Sepideh Attal

5

1 reference

28 August 2017

Damianos Menegas

6

1 reference

28 August 2017

Ralf Sprenger

7

1 reference

28 August 2017

Eric Bonnet

8

1 reference

28 August 2017

language of work or name

English

0 references

publication date

7 February 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

30

1 reference

28 August 2017

issue

2

1 reference

28 August 2017

page(s)

127-151

1 reference

Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0007-6

The development of 13-valent pneumococcal conjugate vaccine and its possible use in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0007-6

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0007-6

The worldwide impact of the seven-valent pneumococcal conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0007-6

Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0007-6

Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0007-6

National paediatric immunization program of high risk groups: no effect on the incidence of invasive pneumococcal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0007-6

Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0007-6

Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0007-6

Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0007-6

Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0007-6

Reduction in pediatric invasive pneumococcal disease in the Basque Country and Navarre, Spain, after introduction of the heptavalent pneumococcal conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0007-6

Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0007-6

Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0007-6

Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0007-6

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0007-6

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0007-6

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0007-6

Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a health disparity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0007-6

Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0007-6

Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0007-6

Declining invasive pneumococcal disease mortality in the United States, 1990-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0007-6

Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0007-6

Decreases in case-fatality and mortality rates for invasive pneumococcal disease in Olmsted County, Minnesota, during 1995-2007: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0007-6

Who's calling the shots? Pediatricians' adherence to the 2001-2003 pneumococcal conjugate vaccine-shortage recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0007-6

Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0007-6

Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0007-6

Changing Epidemiology of Invasive Pneumococcal Disease in Canada, 1998–2007: Update from the Calgary‐Area Streptococcus pneumoniae Research (CASPER) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0007-6

The Changing Epidemiology of Invasive Pneumococcal Disease in Aboriginal and Non‐Aboriginal Western Australians from 1997 through 2007 and Emergence of Nonvaccine Serotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0007-6

Changing epidemiology of invasive pneumococcal disease following increased coverage with the heptavalent conjugate vaccine in Navarre, Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0007-6

Epidemiology of Invasive Pneumococcal Disease among Adult Patients in Barcelona Before and After Pediatric 7‐Valent Pneumococcal Conjugate Vaccine Introduction, 1997–2007

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0007-6

10.1007/S12325-013-0007-6

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1031175358

0 references

1 reference